Compare RIO & MCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RIO | MCK |
|---|---|---|
| Founded | 1873 | 1833 |
| Country | United Kingdom | United States |
| Employees | N/A | 51000 |
| Industry | Metal Mining | Other Pharmaceuticals |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.3B | 101.9B |
| IPO Year | N/A | N/A |
| Metric | RIO | MCK |
|---|---|---|
| Price | $81.06 | $829.21 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 13 |
| Target Price | $85.00 | ★ $882.69 |
| AVG Volume (30 Days) | ★ 3.0M | 826.4K |
| Earning Date | 07-30-2025 | 02-04-2026 |
| Dividend Yield | ★ 4.58% | 0.40% |
| EPS Growth | N/A | ★ 66.19 |
| EPS | 6.28 | ★ 32.12 |
| Revenue | $53,729,000,000.00 | ★ $387,094,000,000.00 |
| Revenue This Year | $7.31 | $14.87 |
| Revenue Next Year | $3.52 | $8.33 |
| P/E Ratio | ★ $12.90 | $25.71 |
| Revenue Growth | N/A | ★ 17.23 |
| 52 Week Low | $51.67 | $565.75 |
| 52 Week High | $81.17 | $895.58 |
| Indicator | RIO | MCK |
|---|---|---|
| Relative Strength Index (RSI) | 79.66 | 52.31 |
| Support Level | $74.70 | $813.00 |
| Resistance Level | $81.17 | $825.61 |
| Average True Range (ATR) | 1.10 | 13.41 |
| MACD | 0.50 | 0.57 |
| Stochastic Oscillator | 97.33 | 92.82 |
Rio Tinto is a global diversified miner. Iron ore is the dominant commodity, with significantly lesser contributions from copper, aluminum, diamonds, gold, and industrial minerals. The 1995 merger of RTZ and CRA, via a dual-listed structure, created the present-day company. The two operate as a single business entity, with shareholders in each company having equivalent economic and voting rights. Major assets included the Pilbara iron ore operations, a 30% stake in the Escondida copper mine, 66%-ownership of the Oyu Tolgoi copper mine in Mongolia, the Weipa and Gove bauxite mines in Australia, and six hydro-powered aluminum smelters in Canada.
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.